Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_815_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Series Editors’ preface
- •Editors’ preface
- •Evidence-based practice in surgery
- •Contributors
- •Liver function and failure
- •Hepatic, biliary and pancreatic anatomy
- •Staging and assessment of hepatobiliary malignancies
- •Benign liver lesions
- •Primary malignant tumours of the liver
- •Colorectal liver metastases
- •Non-colorectal hepatic metastases
- •Portal hypertension and liver transplantation
- •Pancreas and islet transplantation
- •The spleen and adrenal glands
- •Gallstones
- •Benign biliary tract diseases
- •Malignant lesions of the biliary tract
- •Complicated acute pancreatitis
- •Chronic pancreatitis
- •Pancreatic adenocarcinoma
- •Cystic and neuroendocrine tumours of the pancreas
- •Hepatobiliary and pancreatic trauma

Chapter 13
• Chemotherapy and radiotherapy may have benefit in the adjuvant setting but currently remain
investigational.
• The clinical presentation in distal cholangiocarcinoma is very similar to that of other periampullary
tumours.
• Similar to hilar disease, a preoperative tissue diagnosis is not necessary to proceed with surgical
resection.
• When possible, endoscopic palliation is the preferred method to relieve symptomatic jaundice in the
setting of unresectable disease.
• Hepatocellular carcinoma must be excluded in patients with an intrahepatic mass.
• Metastatic adenocarcinoma to the liver from a remote primary, such as lung, breast or
gastrointestinal, must be excluded.
• Similar to all other locations of cholangiocarcinoma, complete surgical resection of an intrahepatic
cholangiocarcinoma is the optimal treatment and only chance for cure.
• In gallbladder cancer, a cholecystectomy should be performed for adenomatous polyps >1 cm,
or those that are smaller but growing and changing in character. Cholesterol polyps and
adenomyomatosis are not premalignant conditions.
• Complete surgical resection is the goal, whether the diagnosis is made preoperatively,
intraoperatively or after a non-curative laparoscopic cholecystectomy.
• In patients with invasion into the common bile duct, consideration should be given to neoadjuvant
chemotherapy prior to surgical exploration in an attempt to best select patients for potentially
curative resection.
• Obstructive jaundice in the setting of gallbladder carcinoma portends poor survival and systemic
therapy should be considered prior to entertaining surgical resection.
Recommended videos:
• Extended right hepatectomy – https://tinyurl.com/
ybkfl6dp
• Extended left hepatectomy – https://tinyurl.com/
yaseqppf
• Hepatectomy with portal vein resection – https://
tinyurl.com/ya9np7s9
Full references available at http://expertconsult.
inkling.com
Key references
3. Esnaola NF, Meyer JE, Karachristos A, et al.
Evaluation and management of intrahepatic
and extrahepatic cholangiocarcinoma. Cancer
2016;122(9):1349–69. PMID: 26799932.
This current review focuses on recent advances
in the diagnosis and treatment of patients with
cholangiocarcinoma and, in particular, on the role of
endoscopy, surgery, transplantation, radiotherapy,
systemic therapy and liver-directed therapies in the
curative or palliative treatment of these individuals.
57. BismuthH, NakacheR, DiamondT. Management
strategies in resection for hilar cholangiocarcinoma.
Ann Surg 1992;215(1):31–8. PMID: 1309988.
Seminal paper where results indicate that improved
survival in hilar cholangiocarcinoma can be achieved
by resection, with minimal morbidity and zero
mortality rates, if histologically free resection margins
are obtained.
58. JarnaginWR, FongY, DeMatteoRP, etal. Staging,
resectability, and outcome in 225 patients with
hilar cholangiocarcinoma. Ann Surg 2001;234(4):
507–17; discussion 517–9. PMID: 11573044.
By taking full account of local tumour extent, the
proposed staging system for hilar cholangiocarcinoma
accurately predicts resectability, the likelihood of
metastatic disease, and survival. Complete resection
remains the only therapy that offers the possibility of
long-term survival, and hepatic resection is a critical
component of the surgical approach.
59. Matsuo K, Rocha FG, Ito K, et al. The
Blumgart preoperative staging system for hilar
cholangiocarcinoma: analysis of resectability
and outcomes in 380 patients. J Am Coll Surg
2012;215(3):343–55. PMID: 22749003.
The preoperative clinical T-staging system of
Blumgart, defined by the radial and longitudinal
tumour extent, accurately predicts resectability of
242
Downloaded for Anonymous User (n/a) at Rutgers University - NERL from ClinicalKey.com by Elsevier on March 22, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.

Malignant lesions of the biliary tract
hilar cholangiocarcinoma. The full outcomes benefit
of resection is realised only if a concomitant partial
hepatectomy is performed.
64. WiggersJK, Groot KoerkampB, CieslakKP, etal.
Postoperative mortality after liver resection for
perihilar cholangiocarcinoma: development of
a risk score and importance of biliary drainage
of the future liver remnant. J Am Coll Surg
2016;223(2):321–31. e1. PMID: 27063572.
The mortality risk score for patients with resectable
hilar cholangiocarcinoma can be used for patient
counselling and identification of modifiable risk
factors, which include FLR volume, FLR drainage
status, and preoperative cholangitis. No evidence to
support preoperative biliary drainage in patients with
an FLR volume >50% was identified.
76. Ribero D, Abdalla EK, Madoff DC, etal. Portal
vein embolization before major hepatectomy
and its effects on regeneration, resectability and
outcome. Br J Surg 2007;94(11):1386–94. PMID:
17583900.
This study evaluated the safety of portal vein
embolisation (PVE), its impact on future liver remnant
(FLR) volume and regeneration, and subsequent
effects on outcome after liver resection.
94. ChengQB, Yi B, WangJH, etal. Resection with
total caudate lobectomy confers survival benefit
in hilar cholangiocarcinoma of Bismuth type III
and IV. Eur J Surg Oncol 2012;38(12):1197–203.
PMID: 22992326.
Study to identify prognostic predictors for overall
survival of patients with hilar cholangiocarcinoma
of Bismuth type III and IV, and to determine survival
benefit and safety of total caudate lobectomy.
Resection with total caudate lobectomy offers a
long-term survival opportunity for patients with hilar
cholangiocarcinoma, with high curative resectability
rates and an acceptable safety profile.
97. Neuhaus P, Jonas S, Bechstein WO,
et al. Extended resections for hilar
cholangiocarcinoma. Ann Surg 1999;230(6):
808–18; discussion 819. PMID: 10615936.
Extended resections, especially right
trisegmentectomy resulted in the highest rate of R0
resection. Right trisegmentectomy together with
portal vein resection best represents the principles
of surgical oncology and may be regarded as the
surgical procedure of choice.
105. PrimroseJN, FoxR, PalmerDH, et al. Adjuvant
Capecitabine for biliary tract cancer: The BILCAP
randomized study. Journal of Clinical Oncology
2017;35(15_suppl):4006.
The results of the BILCAP trial will shape the
practice of adjuvant therapy after resection of biliary
tract malignancies. Given these data, adjuvant
capecitabine will likely become the new standard
of care for patients undergoing upfront resection of
biliary tract malignancy.
123. ValleJ, WasanH, PalmerDH, etal. Cisplatin plus
gemcitabine versus gemcitabine for biliary tract
cancer. N Engl J Med 2010;362(14):1273–81.
PMID: 20375404.
This study shows a significant survival advantage for
cisplatin plus gemcitabine over gemcitabine alone in
patients with advanced biliary cancer. Cisplatin plus
gemcitabine is an appropriate option for treatment of
these patients.
131. KonstantinidisIT, Groot KoerkampB, DoRK, etal.
Unresectable intrahepatic cholangiocarcinoma:
systemic plus hepatic arterial infusion
chemotherapy is associated with longer survival
in comparison with systemic chemotherapy alone.
Cancer 2016;122(5):758–65. PMID: 26695839.
In patients with unresectable intrahepatic
cholangiocarcinoma confined to the liver or with
limited regional nodal disease, a combination of
systemic therapy and hepatic arterial infusion
chemotherapy is associated with greater survival than
systemic alone.
135. D’Angelica M, Dalal KM, DeMatteo RP,
et al. Analysis of the extent of resection for
adenocarcinoma of the gallbladder. Ann Surg
Oncol 2009;16(4):806–16. PMID: 18985272.
Tumour biology and stage, rather than extent of
resection, predict outcome after resection for
gallbladder cancer. Major hepatic resections,
including bile duct excision, are appropriate when
necessary to clear disease but are not mandatory in
all cases.
Downloaded for Anonymous User (n/a) at Rutgers University - NERL from ClinicalKey.com by Elsevier on March 22, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.
243

14
14
Complicated acute pancreatitis
Euan J. Dickson
C. Ross Carter
Colin J. McKay
Introduction
Complications following acute pancreatitis
occur on a spectrum of severity, complexity and
chronology. The majority of patients with acute
pancreatitis (AP) recover with simple supportive
management including intravenous fluids and
analgesia. Approximately 20%, however, develop
severe acute pancreatitis with local and/or systemic
complications. Of this subgroup, up to half will die
as a result of complications of their disease.
Successful management of the patient with
complications following AP is challenging and
best undertaken by a multidisciplinary team.
Decision-making is complex, multimodal therapy is
often required and the hospital stay is likely to be
protracted. Increasingly, these patients are managed,
at least initially, in the base hospital. Early and regular
discussion with a specialist unit is recommended
and those patients who exceed local institutional
capability should be considered for transfer.
Initial management
The initial management of acute pancreatitis is
covered in the relevant chapter of the Core Topics
in General and Emergency Surgery volume of
this series and is addressed in several guidelines
and consensus statements. The most recent and
relevant of these is the International Association
of Pancreatology/American Pancreatic Association
Guidelines of 2013 (IAP/APA Working Group
1
This chapter will therefore focus on the
2013).
management of complications of acute pancreatitis.
Key concepts
There are three key concepts in the current
management of complications of acute pancreatitis
(Box14.1).
Definitions and terminology
in acute pancreatitis
The original Atlanta Classification of acute
pancreatitis was published in 1993
to define the disease and clarify the terminology.
Over the subsequent two decades, understanding
of the correlation between clinical, radiological
and pathological features has improved. This is
largely as a result of advances in medical imaging
technology and, in particular, contrast enhanced
computed tomography (CECT).
The revised Atlanta Classification was published
3
in 2013
deficiencies and confusion inherent in the previous
definitions. Two phases of the disease process are
identified: early and late, arbitrarily defined as
less than/more than 4 weeks from presentation.
A third category has been added to disease severity,
which is now classified as mild, moderate or severe
(Box14.2).
The ability to interpret fluid collections and
necrosis is critical to decision-making regarding
management, particularly intervention. The revised
Atlanta Classification of these local complications
is a significant improvement over the original
definitions. Local fluid collections are now defined
based on time from presentation and content,
and sought to address the recognised
2
in an effort
244
Downloaded for Anonymous User (n/a) at Rutgers University - NERL from ClinicalKey.com by Elsevier on March 22, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.

Complicated acute pancreatitis
Box14.1 • Complications of acute pancreatitis
1. Patient pathophysiology, rather than anatomy of disease,
determines the need for intervention. Serial clinical
review identifies global trends in patient trajectory and
guides management.
2. If intervention is considered necessary it should in
general be delayed for as long as possible (unless
immediately life-saving) and is best avoided in the first
2 weeks following the index episode.
3. Each intervention carries risk and benefit – therapeutic
gain is maximised when the intervention is limited
to that which is absolutely necessary (the ‘step-up
approach’). Radiological, endoscopic and other minimally
invasive techniques are replacing major open surgical
intervention.
Box14.2 • Revised Atlanta Classification (2012)
Mild acute pancreatitis
– no organ failure, local or systemic complications and
usually resolves within a week
Moderately severe acute pancreatitis
– transient organ failure, local complications or exacerbation
of comorbid disease
Severe acute pancreatitis
– persistent organ failure (duration >
48 hours)
as acute peripancreatic fluid collections (APFC),
pseudocyst, acute necrotic collection (ANC) and
walled-off necrosis (WON). Collections may be
sterile or infected. The management of each of
these differs and is outlined below with the updated
definitions.
Acute peripancreatic fluid collection (APFC)
In the early stages of acute pancreatitis, up to
25% of patients will develop a fluid collection in
the peripancreatic region. On contrast-enhanced
computed tomography (CECT), APFCs are illdefined, homogeneous and may be multiple.
Pancreatic vascular perfusion on CECT is normal,
and there should be no necrotic material (e.g.
peripancreatic fat) within the collection. Most
acute fluid collections remain sterile, usually
resolve without intervention and are of little clinical
significance. There are, however, significant risks
associated with aspiration and especially external
drainage. These unnecessary interventions may
introduce infection. Whilst most APFCs resolve
spontaneously, a small number may persist beyond
4weeks and develop into a pancreatic pseudocyst.
Pancreatic pseudocyst
A pancreatic pseudocyst refers specifically to
a fluid collection with no solid component
persisting beyond 4 weeks of presentation. It
is predominantly in the peripancreatic tissues,
although it may be partially or wholly within the
pancreatic parenchyma. With time a well-defined
wall will develop. Most post-acute collections
described as pseudocysts are actually walledoff necrotic collections with a relatively minor
volume of necrosis. Persistence of an acute fluid
collection beyond 4 weeks is thought to result
from disruption of the main pancreatic duct or
its side branches, and the fluid within has a very
high amylase content. Disruption of the duct will
only occur following necrosis of either the duct
or parenchyma and pancreatic necrosis must be
present by definition. Therefore, a pancreatic
pseudocyst is extremely rare in acute pancreatitis
and most persistent collections should be thought
of and managed as walled-off necrotic collections.
CECT often underestimates the degree of solid
material and MRI or EUS may be required to
determine the volume of necrosis.
Asymptomatic or small pseudocysts do not
require treatment, and many will eventually
resolve spontaneously. Acute pseudocysts are
most commonly retrogastric, and may or may not
communicate with a disrupted pancreatic duct.
Three-quarters will be associated with a mild to
moderate hyperamylasaemia.
Necrosis
The revised Atlanta Classification dichotomises
necrosis according to the phase of the disease
process, with an arbitrary cut-point at 4weeks.
Acute necrotic collection
Acute necrotic collection (ANC) is the terminology
used to describe a fluid collection with a solid
necrotic component within the first 4 weeks
following presentation. The fluid and solid
components occur in variable proportions. It is
therefore distinct from an APFC, which contains
fluid only. The necrotic process may involve both
the pancreas and peripancreatic tissues. On CECT
these collections may be multiple, ill-defined and
loculated.
Walled-off necrosis
Walled-off necrosis (WON) also contains necrosis
but occurs later in the disease process (after
4weeks). On CECT it has a well-defined, mature,
enhancing wall of reactive tissue and contains fluid
and solid necrotic material. The nomenclature
of this entity has perhaps undergone the greatest
number of revisions over the last few decades and
these are not revisited here in an effort to minimise
confusion. WON can also occur at multiple sites,
which may or may not communicate with each other,
and can extend to more distant areas including the
mesentery, making access challenging.
Downloaded for Anonymous User (n/a) at Rutgers University - NERL from ClinicalKey.com by Elsevier on March 22, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.
245

Chapter 14
Sterile and infected collections
As will be discussed later, the development of
infection within a collection has a profound effect on
the clinical course and the need for intervention. All
collections can become infected but this is unusual
in the absence of necrosis, and infected acute fluid
collections or pseudocysts are rare. Sepsis almost
universally presents as an infected ANC or infected
WON, the management of which will be discussed
in a subsequent section. Infection may occur at any
stage but is most frequent in the second and third
weeks following presentation, and may be suspected
through clinical deterioration, usually associated
with a rising inflammatory response, and should
prompt urgent CT.
Local complications of acute pancreatitis are
defined by time (< / > 4weeks) and by necrosis
(present or absent).
Clinical patterns and complications
Complications of acute pancreatitis may be
broadly considered as systemic or local. These are
inextricably linked and both may be present to
varying degrees.
The clinical progress of a patient with pancreatitis,
including the development of systemic or local
complications is not a binary process but rather a
dynamic continuum with the potential for rapid
deterioration. Within this continuum, patterns of
clinical behaviour are apparent.
Early phase complications (<
Systemic complications
Organ failure
The majority of patients with clinically mild
acute pancreatitis may be managed in a ward
environment. Patients with evidence of clinical
deterioration, and in particular those with persistent
organ dysfunction, should be managed in a critical
care environment. Early indication for critical care
support is usually as a result of an uncontrolled
systemic inflammatory response resulting in organ
failure. Late deterioration requiring critical care
support is often the consequence of inadequately
controlled sepsis, which is a risk factor for lifethreatening haemorrhage, and often precedes
terminal decline.
Severe acute pancreatitis is frequently associated
with organ failure. Respiratory, cardiovascular,
renal and gastrointestinal dysfunction are the
most commonly involved systems. Deteriorating
organ function mandates critical care support in
the high dependency unit (HDU) or intensive care
unit (ICU).
4 weeks)
Respiratory failure should prompt early discussion
with the critical care team. Whilst non-invasive
respiratory support may be sufficient for some
patients, others require early mechanical ventilation
and the transition from one level of support to the
other can be rapid.
Cardiovascular collapse is treated with aggressive
volume resuscitation directed towards optimising
tissue perfusion. This should include addressing both
haemodynamic targets and parameters of cellular
respiration. Acid–base balance, lactate and mixed
venous oxygen saturation are helpful in assessing
adequacy of volume restoration. Vasoactive support
is often required as a bridge whilst restoring
circulating volume.
Renal failure as a consequence of cardiovascular
compromise and reduced perfusion is common.
Management again involves prompt volume resuscitation and close attention to fluid balance. Dialysis
may be required for fluid overload, hyperkalaemia
or acidosis. Recovering renal function in this
context is a helpful marker of global improvement
in physiology.
Reduced visceral perfusion may also result in
gastrointestinal dysfunction. Gastrointestinal
blood flow is further compromised by splanchnic
vasoconstriction, either as a consequence of shock
physiology or secondary to exogenous vasoconstrictor
support. This manifests as abdominal bloating,
nausea and vomiting and has two significant clinical
sequelae. Firstly, patients may be unable to tolerate
enteral nutrition including nasojejunal feeding.
Secondly, inadequate mucosal perfusion leads to
breakdown of the intestinal barrier function and is
associated with bacterial translocation and infection
of pre-existing necrosis.
Deteriorating physiology should prompt early
critical care input regardless of ‘predicted severity’.
Intra-abdominal hypertension (IAH)
IAH is recognised as a contributing factor to organ
dysfunction in the context of a variety of acute
abdominal processes. Most of the literature to date
focuses on trauma patients, but there is increasing
interest in its role in patients with severe acute
pancreatitis. There are data to suggest that raised
intra-abdominal pressure (IAP) may be associated
with disease severity, organ failure and mortality in
severe acute pancreatitis.
There are, however, no data to suggest improved
outcome following surgical decompression for raised
IAP in acute pancreatitis, and indeed this may be
harmful. Abdominal compartment syndrome (raised
IAP with associated organ failure) should initially be
managed medically according to existing guidelines.
4
A decision to proceed to decompressive laparostomy
246
Downloaded for Anonymous User (n/a) at Rutgers University - NERL from ClinicalKey.com by Elsevier on March 22, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.

Complicated acute pancreatitis
may be made on an individual case basis within a
multidisciplinary team setting, but there is currently
no evidence base for this approach.
There is currently no evidence base for the role
of decompressive laparostomy in acute pancreatitis.
The role of ERCP in acute pancreatitis
There has been long-standing controversy over
the role and timing of endoscopic retrograde
cholangiopancreatography (ERCP) in gallstone
pancreatitis, with conflicting results from randomised
trials. However, there are now several meta-analyses
of the randomised evidence clarifying the position.
5,6
There is no role for early ERCP in mild pancreatitis.
Following complete resolution of mild gallstone
pancreatitis there may be a role for ERCP and
sphincterotomy as definitive management where
cholecystectomy is precluded by comorbidity.
7
In patients with severe disease, there is a subgroup
that present with hyperamylasaemia, pain,
jaundice and fever within 12 hours of presentation.
Early recognition that these patients have organ
dysfunction secondary to biliary sepsis rather than
pancreatitis, the hyperamylasaemia being incidental,
should prompt an ERCP and biliary decompression.
A management dilemma, however, exists in the
subgroup of patients with acute pancreatitis and
jaundice as it may be difficult to differentiate
between the systemic inflammatory response
syndrome (SIRS) driven by acute pancreatitis and
‘true’ cholangitis. There is a lack of clear evidence
regarding the role of early ERCP in patients with
pancreatitis and jaundice but without evidence
of cholangitis. In addition, unnecessary ERCP
carries risk and may be technically challenging
in the context of duodenal and periampullary
oedema. The majority of duct stones causing acute
pancreatitis are expected to pass spontaneously, and
it may therefore be helpful to observe these patients
for 24–48 hours and then divide them into one
of three groups to determine if there is a need for
ERCP (Box14.3).
Box14.3 • ERCP algorithm for acute pancreatitis
1. Patients with resolving jaundice
– observe
2. Patients with persistent jaundice but clinically improving
– biliary imaging with MRCP or EUS
3. Patients with persistent jaundice and clinical
deterioration
– ERCP and biliary decompression
ERCP, endoscopic retrograde cholangiopancreatography; EUS,
endoscopy-guided ultrasound; MRCP, magnetic resonance
cholangiopancreatography.
Early haemorrhage
In the era of early surgical debridement, the term
haemorrhagic pancreatitis
8
was often used to describe
the presence of blood within the necrotic pancreatic
and peripancreatic tissue found at laparotomy.
Active haemorrhage is, however, extremely rare in
the acute phase in the absence of intervention.
Colonic ischaemia
Mesenteric vascular compromise is extremely
common in severe acute pancreatitis, usually as
part of global systemic hypoperfusion. Mucosal
hypoperfusion has been postulated as a potential
source of secondary infection of acute necrotic
collections.
9
This is believed to be modulated
through bacterial translocation as a result of a
breakdown in the mucosal barrier. At laparotomy
and debridement, the vascular integrity of the colon
often appears questionable, leading to a relatively
high incidence of colectomy. Full-thickness
intestinal ischaemia is fortunately relatively rare,
and is seen much less frequently in the minimally
invasive era. Patchy full-thickness ischaemia may
lead to fistulation with secondary sepsis (Fig.14.1).
Defunctioning ileostomy may be required for sepsis
control.
Late complications (>
4 weeks)
Management of collections associated
with acute pancreatitis
Management of necrosis
As previously stated, intervention is usually required
only for ANC or WON, the majority of acute fluid
collections resolving spontaneously. The management
algorithm for pancreatic necrosis has altered radically
in the last 20years in response to evolving concepts,
improved understanding of the disease process and the
development of minimally invasive techniques. These
techniques include percutaneous,
and endoscopic drainage
10–12
14,15
laparoscopic13
procedures as an
alternative to conventional open debridement.
The necrotic process associated with pancreatitis
tends to involve both the pancreatic parenchyma and
surrounding adipose tissue. Significant quantities of
necrotic peripancreatic tissue can be present with an
essentially viable gland. Complications relate to the
extent of the necrotic process, and in particular the
extent of parenchymal necrosis.
It is key to recognise that the presence of necrosis
in itself is not an indication for intervention. The
previously held concept that recovery would not
occur until almost complete removal of necrosis had
been achieved
16
has been progressively challenged
and the focus of intervention is now on the ‘adequate
and maintained control of sepsis’. The PANTER
17
demonstrated that 35% of patients will resolve
trial
completely without necrosectomy in the absence of
Downloaded for Anonymous User (n/a) at Rutgers University - NERL from ClinicalKey.com by Elsevier on March 22, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.
247

Chapter 14
a b
Figure14.1 • Colonic ischaemia with fistulation. (a) Gas within acute necrotic collection in the head of pancreas,
oedematous colon and free intraperitoneal gas and fluid levels laterally. (b) Portal pyaemia with gas within the peripheral
intrahepatic portal venous radicals.
sepsis. Given sufficient time, ‘organisation’ occurs –
solid components within a collection are gradually
broken down through enzymatic and phagocytic
activity, and pancreatic necrosis may resolve
completely with resultant fibrosis and atrophy.
Successful management involves individualised
multimodal care, selecting the appropriate
intervention and technique for each stage of the
patient pathway. A multidisciplinary approach has
evolved, and it is now common for several different
techniques to be utilised in an individual patient.
The choice of intervention is dictated by physiology,
anatomy and timing of disease and is underpinned by
an understanding of the dynamic evolution of postacute, necrosis-associated collections in pancreatitis.
The success of various approaches will be dependent
on the anatomical position of the collection and
particularly the ratio of solid to fluid components.
The proess of maturation or ‘organisation’ takes in
excess of 12weeks to complete, during which four
stages can be recognised (Box14.4).
Historically, early aggressive debridement in the
absence of infection was advocated. However, mortality
Box14.4 • Evolution of pancreatic necrosis/collections
1. True pancreatic necrosis – minimal separation of
devitalised tissue with a high solid/fluid ratio.
2. Transitional pancreatic necrosis with partial but
incomplete separation.
3. Walled-off necrosis (WON) – good separation of
devitalised tissue within a fluid-filled cavity and formation
of a fibrous wall lined with granulation tissue.
4. Pseudocyst – almost complete resolution of any solid
component and a well-formed fibrous wall lined with
granulation tissue.
in this setting was high, and the only randomised
study of early versus late (>
12 days) necrosectomy18
was discontinued as a result of the mortality rate in
the early treatment group (56% vs 27%). The general
principle is now to withhold surgery in the early phase
of disease, operating for complications ideally once the
acute inflammatory insult has subsided.
Indications for intervention
There are three main indications for intervention:
sepsis, symptoms or persistence of the collection
over several months. Early drainage (<
6 weeks)
may be potentially harmful by introducing infection
into a poorly defined collection. Minimally invasive
techniques often require sequential procedures
within an established management protocol and
should not be undertaken in isolation.
There is no role for the early drainage of acute
collections in the absence of suspected sepsis. Clinical
deterioration usually manifests through an escalation
in the Early Warning Score,
19
along with a rise in
biochemical or haematological markers of sepsis.
Suspected sepsis mandates urgent CT confirmation
of the diagnosis, resuscitation, antimicrobial therapy
and prompt drainage for control. Of note, in the
deteriorating patient with clinical evidence of sepsis,
the absence of gas in a collection does not exclude
infected necrosis. Although fine-needle aspiration
of the collection to confirm or refute infection has
been advocated,
20
the authors do not recommend it.
In the patient with escalating SIRS or multiple organ
dysfunction syndrome (MODS) and a drainable
collection, percutaneous or endoscopic drainage should
be performed within a step-up context, and positive
culture of the aspirate is almost universally present.
A caveat exists where there is a clinical radiological
mismatch on CECT (i.e. the patient is well but there
248
Downloaded for Anonymous User (n/a) at Rutgers University - NERL from ClinicalKey.com by Elsevier on March 22, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.

Complicated acute pancreatitis
protocol-driven management in the 1990s, aimed at
the early identification of secondary infection within
necrosis. The authors’ approach has progressed from
one based on the presence or absence of infection to
one based on time from onset, organ dysfunction
and anatomical position of the collection.
Methods of sepsis control
The traditional approach to infected necrosis was
open laparotomy/debridement. These approaches
are falling from favour with increasing evidence
that minimally invasive intervention may reduce
morbidity/mortality;
remains the method of choice in some countries.
21
however, open debridement
Figure14.2 • Radiological mismatch – extensive gas
within an acute necrotic collection following foregut
fistulation in an otherwise clinically well patient.
is gas present in the collection, see Fig.14.2), and
the possibility of spontaneous discharge of the
collection into an adjacent hollow viscus should
be considered. In this scenario, whilst bacterial
colonisation of the collection will have occurred,
spontaneous discharge may result in resolution
without intervention.
Symptoms requiring intervention include pain,
early satiety and gastric outlet obstruction, the latter
two arising from the local mass effect of the WON in
relation to the stomach. Intervention for symptoms
is not required with the same degree of urgency and
there is often a place for nutritional optimisation
with enteral feeding to allow the WON to ‘mature’
or even resolve.
Persistence of WON over several months is a
relative indication for intervention and should be
balanced against the individualised risks of the
proposed procedure. Once the decision has been
made to intervene, the options include percutaneous,
endoscopic, laparoscopic or surgical drainage.
This choice is largely determined by institutional
capabilities, patient physiology and the position of
the WON relative to other structures, particularly
the stomach.
There are three indications for intervention on
collections: sepsis, symptoms and failure of
resolution.
Minimally invasive approaches to infected necrosis
Minimally invasive surgery provokes a reduced
inflammatory response when compared to equivalent
open surgery, and there is experimental evidence
suggesting that local sepsis and the inflammatory
response may be lessened by a minimally invasive
rather than an open technique.
The PANTER trial and several prospective
cohort series have suggested that by avoiding the
massive inflammatory ‘hit’ of open pancreatic
necrosectomy, a minimally invasive approach to
infected pancreatic necrosis may reduce the risk of
post-procedural organ failure and wound morbidity.
17,21
However, there is as yet no evidence that one
minimally invasive approach is superior to
another,
22
and the choice of modality is dependent
on the anatomical position of the collection and the
available local skills and resources.
Percutaneous drainage
Freeny et al.,
10
combining aggressive CT-guided
percutaneous drainage (PCD) with continuous
post-drainage lavage, demonstrated resolution of
pancreatic abscesses in nearly 50% of patients. The
remaining patients required subsequent surgical
intervention for residual sepsis. Drain occlusion is
common due to necrotic debris and repeated drains
may be necessary. Simple drainage, even with smalldiameter drains, may be associated with complete
resolution and within the PANTER trial
17
‘step-up’
arm, 35% of patients were successfully managed by
small-bore (4-mm) percutaneous drainage alone.
Sepsis control in an infected acute
necrotic or walled-off collection (early
phase, 2–6weeks)
Infected pancreatic necrosis has previously been
described as the most feared surgical complication
of acute pancreatitis. This led to the development of
Downloaded for Anonymous User (n/a) at Rutgers University - NERL from ClinicalKey.com by Elsevier on March 22, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.
Minimally invasive surgery
Control and prevention of recurrent sepsis is core to
recovery. Inadequate control leads to failure to progress
and an increased rate of secondary complications
(e.g. bleeding). Enhanced percutaneous drainage
(+/– percutaneous necrosectomy) aims to optimise
sepsis control. Sequential drain tract dilatation
249

Chapter 14
allowing insertion of a large bore (30-Fr) doublelumen lavage system is the simplest ‘step-up’ approach
over PCD. Formal debridement using a urological
rigid-rod lens system can remove devitalised tissue
and prevent drain blockage. In other centres as well
as within our own patient cohort, this technique has
significantly reduced mortality.
The Dutch Pancreatitis Study Group have
popularised a video-assisted retroperitoneal debridement technique23 (VARD) using a variation of the
Fagniez technique
24
through a small, 5-cm incision
in the left flank. Their management approach
has evolved from being initially performed on all
patients with infected necrosis, to now being used
as a ‘step-up’ approach should initial PCD fail to
control sepsis. The Dutch group has completed
a randomised trial comparing this minimally
invasive two-stage ‘step-up’ approach with open
necrosectomy
17
and has shown a reduction in early
organ failure (respiratory) and late morbidity, but
the study was underpowered to address mortality.
Endoscopic necrosectomy
The principle of tract dilatation and minimally
invasive necrosectomy has also been used with
the endoscopic approach. Seifert et al.
25
have
reported the dilatation of an endocyst-gastrostomy
tract, allowing insertion of the endoscope into
the retroperitoneum and subsequent piecemeal
debridement. More recently, the use of multiple
transgastric cystgastrostomy puncture sites has
been reported, allowing nasocystic lavage and
stent-assisted drainage through alternative drainage
sites with good sepsis control. Lumen-opposing
stents (Hot AXIOS) allow rapid decompression
of necrosis-associated WON, and are often the
treatment of choice in a critically ill patient as
this can be performed at the bedside in the ICU.
It is essential that a post-drainage protocol is
followed to prevent blockage of the cystgastrostomy
with recurrent sepsis. Although extremely effective
as an initial intervention, increased use has seen
a relatively high incidence of stent-associated
morbidity, with recurrent sepsis, haemorrhage and
stent migration being described (Fig.14.3).
There is currently no evidence that one
minimally invasive technique has any advantage
over another and choice is often determined by
institutional capability.
Open laparotomy/debridement
Although the method of choice in the 1980s, open
surgery and debridement is now relatively uncommon
in most UK specialist centres. As originally described,
the complete exposure of the retroperitoneum, with
mobilisation of both colonic flexures originally arose
through the unavailability of adequate axial scanning.
A more limited laparotomy focused on adequate
drainage of acute necrotic or walled-off collections
identified on CECT has been suggested by some as
a superior alternative in a fit patient with no organ
compromise (Fig.14.4). This may allow rapid recovery
and avoid the repeated interventions and prolonged
hospital stay associated with minimally invasive
procedures. This approach is most appropriate where
the collection has matured and complete separation
of the necrosis has occurred. Fig. 14.4 illustrates
the exposed SMA following open evacuation of
haematoma following a bleed into a walled off
necrotic cavity. Adequate and definitive drainage can
a b
Figure14.3 • Complications of EUS-guided cystgastrostomy. (a) Internal migration of SEMS; (b) intraluminal migration
with small bowel obstruction.
250
Downloaded for Anonymous User (n/a) at Rutgers University - NERL from ClinicalKey.com by Elsevier on March 22, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.

Figure14.4 • Open necrosectomy following acute
haemorrhage managed by interventional radiological
embolisation of a branch of the superior mesenteric artery,
with loss of the head and uncinate process.
then be achieved through a single intervention, often
draining a collection through the posterior wall of the
stomach (cystgastrostomy). This can be performed at
open surgery or by laparoscopy.
Where organisation is incomplete, usually as a
result of early intervention being mandated for
sepsis, incomplete debridement carries a high
incidence of recurrent sepsis, and several methods
of maintaining sepsis control following debridement
have been described. The commonest approach
is closed lavage, popularised by Beger,
laparostomy
27
or closed packing28 approaches are
26
but open
equally effective, and the method of choice often
reflects local experience.
Retrocolic/perineal/mesenteric necrosis
Peripancreatic extension of the necrotic process
commonly follows fat planes into the small
bowel or colonic mesentery. It may also extend
extraperitoneally behind the colon and abdominal
wall, occasionally reaching the perineum. Adequate
drainage of mesenteric extension without
compromising the vasculature can be challenging,
and patience is often rewarded. Retrocolic extensions
often require multimodal, minimally invasive access
drainage at several sites and, particularly with
horseshoe collections, the VARD approach can be
particularly useful (Fig.14.5).
Open surgery has largely been replaced by
minimally invasive alternatives, but may
occasionally be required to achieve control
of sepsis and/or bleeding.
Nutritional support
Acute pancreatitis, particularly in the context of
complications, is often a prolonged and profoundly
catabolic illness. Nutritional insufficiency should
Complicated acute pancreatitis
be anticipated and managed proactively. There are
two important but distinct considerations: (1) the
mode of nutritional delivery, and (2) the potential
to impact the disease process through the use of
immunomodulating feeds.
Nutritional delivery in the patient with acute
pancreatitis
The traditional management of acute pancreatitis
was to promote gut rest and address nutritional
requirements parenterally, yet there is no evidence
to support this. The early randomised studies of
total parenteral nutrition (TPN) versus fasting,
enteral feeding
30
demonstrated a negative effect of
TPN, as a result of TPN-associated side-effects.
A Cochrane review including eight
randomised trials, demonstrated a reduction in
mortality, systemic complications and surgical
intervention in patients given enteral nutrition.
Most experience to date has been with enteral feeding
distal to the duodenojejunal flexure. More recently,
nasogastric (NG)
31a
feeding has been shown to be a
practical alternative to jejunal feeding. All studies
in this area are underpowered but in the absence of
definitive evidence it is reasonable to attempt this route
prior to considering nasojejunal (NJ) tube support.
It is important to recognise that there are situations
where parenteral nutrition must be considered. These
include failure to meet nutritional requirements with
enteral feeding, complex gastrointestinal fistulas and
high output losses such as intractable diarrhoea.
Occasionally, a combination of enteral and parenteral
support is required, for example when enteral feed
is not adequately absorbed. A multidisciplinary
approach with nutrition team input is imperative,
regardless of the route of feeding.
In summary, oral or enteric nutrition is the
preferred route in acute pancreatitis. There is no
requirement to fast patients with acute pancreatitis,
assuming diet is tolerated. Normal diet may be
augmented with commercially available nutritional
supplements. If this is inadequate, NG feeding may
be attempted followed by NJ support if this also
fails. Finally, TPN should only be used when enteral
options are exhausted or contraindicated for the
reasons outlined above (Box14.5).
Disease modulation through content or mode
of delivery
There has been interest in the role of the intestine
in the pathophysiology of multiple organ failure
in critical illness, with loss of gut barrier function
potentially leading to endotoxaemia and SIRS.
These are largely non-clinical data but a small
study from the authors reported a reduction in the
29
or
31
Downloaded for Anonymous User (n/a) at Rutgers University - NERL from ClinicalKey.com by Elsevier on March 22, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.
251
Соседние файлы в папке Библиотека им академика М.И. Перельмана
